Literature DB >> 28495686

Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: a community-based cohort.

Ane Aamli Gagnat1, Miriam Gjerdevik2,3, Frode Gallefoss4, Harvey O Coxson5, Amund Gulsvik4, Per Bakke4.   

Abstract

There is limited knowledge about the prognostic value of quantitative computed tomography (CT) measures of emphysema and airway wall thickness in cancer.The aim of this study was to investigate if using CT to quantitatively assess the amount of emphysema and airway wall thickness independently predicts the subsequent incidence of non-pulmonary cancer and lung cancer.In the GenKOLS study of 2003-2005, 947 ever-smokers performed spirometry and underwent CT examination. The main predictors were the amount of emphysema measured by the percentage of low attenuation areas (%LAA) on CT and standardised measures of airway wall thickness (AWT-PI10). Cancer data from 2003-2013 were obtained from the Norwegian Cancer Register. The hazard ratio associated with emphysema and airway wall thickness was assessed using Cox proportional hazards regression for cancer diagnoses.During 10 years of follow-up, non-pulmonary cancer was diagnosed in 11% of the subjects with LAA <3%, in 19% of subjects with LAA 3-10%, and in 17% of subjects with LAA ≥10%. Corresponding numbers for lung cancer were 2%, 3% and 11%, respectively. After adjustment, the baseline amount of emphysema remained a significant predictor of the incidence of non-pulmonary cancer and lung cancer. Airway wall thickness did not predict cancer independently.This study offers a strong argument that emphysema is an independent risk factor for both non-pulmonary cancer and lung cancer.
Copyright ©ERS 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28495686     DOI: 10.1183/13993003.01162-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Effect of Hypercapnia, an Element of Obstructive Respiratory Disorder, on Pancreatic Cancer Chemoresistance and Progression.

Authors:  Avinoam Nevler; Samantha Z Brown; David Nauheim; Carla Portocarrero; Ulrich Rodeck; Jonathan Bassig; Christopher W Schultz; Grace A McCarthy; Harish Lavu; Theresa P Yeo; Charles J Yeo; Jonathan R Brody
Journal:  J Am Coll Surg       Date:  2020-02-11       Impact factor: 6.113

Review 2.  Phenotype of Chronic Obstructive Pulmonary Disease Based on Computed Tomography-Defined Underlying Pathology.

Authors:  Won-Dong Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-07-13

3.  Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules.

Authors:  Johanna M Uthoff; Sarah L Mott; Jared Larson; Christine M Neslund-Dudas; Ann G Schwartz; Jessica C Sieren
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

4.  Acute exacerbations of COPD and risk of lung cancer in COPD patients with and without a history of asthma.

Authors:  Ane Aamli Gagnat; Miriam Gjerdevik; Stein Atle Lie; Amund Gulsvik; Per Bakke; Rune Nielsen
Journal:  Eur Clin Respir J       Date:  2020-08-07

5.  Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD.

Authors:  Kaschin Jamal Jameel; Willem-Jakob Gallert; Sarah D Yanik; Susanne Panek; Juliane Kronsbein; David Jungck; Andrea Koch; Jürgen Knobloch
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

6.  Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.

Authors:  Qi Ding; Xia Wei; Jie Li; Yan-Zhong Gao; Shu-Di Xu; Nan Yu; Jiu-Yun Mi; Bai-Bing Mi; You-Min Guo
Journal:  Can Respir J       Date:  2021-10-13       Impact factor: 2.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.